Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Datametrex AI Limited (DM.V)
Toronto, ON, CA
Datametrex AI Limited, alongside its various divisions, specializes in leveraging proprietary machine learning and artificial intelligence technologies to gather, process, and present both structured and unstructured data. The company conducts its operations across Canada and South Korea. Its business is strategically organized into two main sectors: AI and Technology, and Health Security. Within the Health Security segment, Datametrex delivers a comprehensive suite of medical services, including support related to COVID-19, personalized concierge medicine, and virtual telehealth consultations. Concurrently, its AI and Technology division provides expertise in big data analytics, artificial intelligence development, and integrated system solutions. The company also supplies COVID-19 diagnostic kits. Furthermore, its offerings encompass specialized platforms such as NexaSecurity, designed for social media discovery and monitoring; Nexalogy's Automated Social Media Reporting Technologies; and dedicated Datametrex EV solutions for electric vehicles. Additionally, Datametrex developed the Medi-Call health application, a subscription-based service that facilitates connections between patients and medical professionals. This app enables technology-driven e-health and m-health services, including the issuance of prescriptions and the arrangement of in-person doctor visits at a patient's home or workplace. Datametrex AI Limited's corporate headquarters are situated in Toronto, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -16.67% | -58.33% | -44.44% | -41.18% | -50.00% | -97.44% | -99.24% | -86.67% | -97.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Information Technology Services: +10.1%-20.0% Q4'25: +14.9% (vs Q4'24)
-
EPS growth Information Technology Services: +16.7%-37.5% Q4'25: -120.2% (vs Q4'24)
-
FCF margin FCF growth · Information Technology Services: +32.8%-175.6% Q4'25: -59.7% (vs Q4'24)
-
EBIT margin Information Technology Services: +9.0%-100.8% Q4'25: -38.0% (vs Q4'24)
-
ROIC Information Technology Services: +9.5%-43.2% Q4'25: -36.0% (vs Q4'24)
-
Share dilution Information Technology Services: +0.0%+250.8% Q4'25: +230.9% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Information Technology Services: -0.83×-1.10× Q4'25: -1.31× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.23M
est: 4.55M (-51.0%)
|
3.40M
est: 3.68M (-7.6%)
|
12.38M
est: 6.07M (+103.9%)
|
49.03M
est: 14.49M (+238.5%)
|
6.49M
est: 4.55M (+42.5%)
|
5.19M
est: 4.55M (+13.9%)
|
3.68M
3.68M – 3.68M
-19.2% YoY
|
6.07M
6.07M – 6.07M
+65.0% YoY
|
14.49M
14.49M – 14.49M
+138.6% YoY
|
| EBITDA |
-3.41M
est: -1.41M (-142.8%)
|
-2.39M
est: -1.14M (-110.7%)
|
-3.61M
est: -1.88M (-92.2%)
|
13.29M
est: -4.47M (+397.2%)
|
-1.24M
est: -1.93M (+35.5%)
|
-4.48M
est: -1.93M (-132.6%)
|
-1.56M
-1.56M – -1.56M
+19.2% YoY
|
-2.57M
-2.57M – -2.57M
-65.0% YoY
|
-6.13M
-6.13M – -6.13M
-138.6% YoY
|
| EBIT |
-6.25M
est: -1.86M (-235.4%)
|
-3.22M
est: -1.51M (-113.6%)
|
-4.36M
est: -2.48M (-75.3%)
|
11.77M
est: -5.93M (+298.5%)
|
-2.60M
est: -2.45M (-6.1%)
|
-5.23M
est: -2.45M (-113.0%)
|
-1.98M
-1.98M – -1.98M
+19.2% YoY
|
-3.27M
-3.27M – -3.27M
-65.0% YoY
|
-7.80M
-7.80M – -7.80M
-138.6% YoY
|
| Net Income |
-19.40M
est: -51.93M (+62.6%)
|
-2.78M
est: -11.54M (+75.9%)
|
-5.01M
est: -5.77M (+13.2%)
|
9.09M
est: 17.31M (-47.5%)
|
-3.06M
est: -182.14M (+98.3%)
|
-5.95M
est: -182.14M (+96.7%)
|
-40.48M
-40.48M – -40.48M
+77.8% YoY
|
-20.24M
-20.24M – -20.24M
+50.0% YoY
|
60.71M
60.71M – 60.71M
+400.0% YoY
|
| SGA |
2.81M
est: 2.38M (+18.3%)
|
2.07M
est: 1.92M (+7.6%)
|
6.52M
est: 3.17M (+105.6%)
|
8.41M
est: 7.56M (+11.2%)
|
3.85M
est: 2.39M (+61.5%)
|
2.78M
est: 2.39M (+16.7%)
|
1.93M
1.93M – 1.93M
-19.2% YoY
|
3.18M
3.18M – 3.18M
+65.0% YoY
|
7.59M
7.59M – 7.59M
+138.6% YoY
|
| EPS |
-2.92
est: -2.70 (-8.1%)
|
-0.37
est: -0.60 (+37.9%)
|
-0.59
est: -0.30 (-96.9%)
|
0.84
est: 0.90 (-6.2%)
|
-0.16
est: -2.70 (+94.1%)
|
-0.22
est: -2.70 (+91.9%)
|
-0.60
-0.60 – -0.60
+77.8% YoY
|
-0.30
-0.30 – -0.30
+50.0% YoY
|
0.90
0.90 – 0.90
+400.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dong H. Shim | Chief Financial Officer | 154.1K | male |
| Bonnie Adamson | MD & Director of Operations - Imagine Health Centres | — | female |
| Cory Taylor | Advisor | — | male |
| Jinsun Choi | Managing Director of DM Korea | — | male |
| Michael Frank | Chief Strategy Officer | — | male |
| Michael Kron | COO & Director | — | male |
| Paul Haber | Chairman & Chief Executive Officer | — | male |
| Andrew R. Male | Advisor | — | male |
| Young Jun Kim | Head of Defense Business Development | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DM.V
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
